News

Home/News
News 2017-06-21T13:15:59+00:00
December 8, 2017
OSE Immunotherapeutics to Resume Accrual in Phase 3 Clinical Trial of Tedopi® in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment
NANTES, France, Dec. 07, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the Independent Data Monitoring Committee (IDMC) has recommended to the ...
December 8, 2017
iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment
NASHUA, N.H., Dec. 07, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the ...
December 8, 2017
Aimmune Therapeutics to Participate in the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that Chief Financial Officer Eric Bjerkholt will participate ...
December 8, 2017
Zealand Pharma initiates the pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
Copenhagen, December 7, 2017 - Zealand Pharma A/S ("Zealand") announces the initiation of the second Phase 3 trial to confirm the clinical efficacy and safety ...
December 8, 2017
Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference
AUSTIN, Texas, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a biotechnology company committed to the discovery and development of engineered human enzyme ...
December 8, 2017
Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology
REDWOOD CITY, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
December 6, 2017
Kiadis Pharma to lease existing commercial manufacturing facility in The Netherlands
AMSTERDAM & DUIVENDRECHT, Netherlands--(BUSINESS WIRE)-- Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative cell ...
December 6, 2017
Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day
LIESTAL, Switzerland, OXFORD, England and CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Santhera Pharmaceuticals (SIX:SANN), Summit Therapeutics (SMMT) (SUMM.L), Catabasis Pharmaceuticals (CATB) and Duchenne ...
December 6, 2017
Pivotal Data for Prometic's Intravenous Plasminogen Replacement Therapy to Be Presented at American Society for Hematology
LAVAL, QC, Dec. 6, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced that it will have two presentations at the 59th American ...
December 6, 2017
Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy
PASADENA, Calif.--(BUSINESS WIRE) -- Arrowhead Pharmaceuticals, Inc. (ARWR) presented new data from the company’s Phase 2 clinical study in patients that received multiple doses of ARC-520, ...
December 6, 2017
Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder
WALTHAM, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
December 6, 2017
Two Independent Poster Abstracts Highlighting The Clinical Efficacy of MiMedx Allografts are Recognized at The 2017 Desert Foot Conference
MARIETTA, Ga., Dec. 6, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue ...
December 6, 2017
BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)-- Regulatory News: Transgene (TNG.PA) (Euronext Paris: TNG), a company that designs and develops viral-based immunotherapies, and BioInvent International AB (OMXS:BINV), focused on ...
December 6, 2017
STRATA Skin Sciences Announces Departure of Chief Financial Officer
HORSHAM, Pa., Dec. 06, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
December 5, 2017
CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases
BERKELEY HEIGHTS, NJ / ACCESSWIRE / December 5, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
December 5, 2017
Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China
SAN DIEGO, Dec. 5, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, and ...
December 5, 2017
Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P with Checkpoint Inhibitor
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan ...
December 5, 2017
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
SAN DIEGO, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some ...
December 4, 2017
Heron Therapeutics Announces Public Offering of Common Stock
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
December 4, 2017
TRACON Pharmaceuticals Announces Appointment of Brian Daniels, M.D., to Scientific Advisory Board
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
Page 1 of 44